Alumis is a clinical-stage biopharmaceutical company specializing in precision medicines for autoimmune disorders. It leverages its proprietary precision data analytics platform and expertise in immunology to develop targeted therapies that significantly improve patients' lives.
Aire Rite
Acquisition in 2023
Aire Rite specializes in the maintenance and installation of HVAC, refrigeration, food machinery and cooking equipment for a range of projects, serving residential and commercial clients across Southern California. The company provides heating, ventilation and air conditioning services, building automation, cooking equipment, predictive maintenance, non-mechanical services, equipment sales and leasing, ice machines and refrigeration services, helping customers improve energy efficiency and reduce operating costs.
CMI Mechanical HVAC and Refrigeration
Acquisition in 2022
CMI Mechanical is a commercial HVAC and refrigeration industry company. It is reinventing how commercial heating and cooling, and mechanical services are provided. It is specialized in boilers, chillers, cooling towers, commercial hvac services, commercial refrigeration, commercial hvac installations, and others.
Arctic Services
Acquisition in 2021
Arctic Services supplies commercial refrigeration and air conditioning equipment. They provide cold room installations, maintenance, repair services, racking systems, and mezzanine flooring services. They install, maintain, and repair refrigeration, air conditioning, and ventilation systems. Their products include counter refrigeration and multi-deck display fridges.
Patriot Mechanical
Acquisition in 2021
Patriot Mechanical has been providing Southern Maine with HVAC repair and maintenance services, such as heating, air conditioning, plumbing, and refrigeration in commercial and residential applications since 2007. We believe in passing our overhead savings on to the customer, working with our customers to stay within their budgets. With an average staff experience of 15 years, you can be reassured that the tech who arrives to perform service for you is reliable and will get the job done the first time.
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative therapies to combat cancer by overcoming resistance mechanisms. The company's lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which plays a significant role in resistance to various cancer treatments across multiple solid tumors. Another key candidate, ORIC-533, is an orally bioavailable inhibitor of CD73, targeting a critical pathway in the adenosine metabolism that contributes to resistance against chemotherapy and immunotherapy. Additionally, ORIC is working on a pipeline of precision medicines aimed at addressing other cancer resistance mechanisms. Founded in 2014 and headquartered in South San Francisco, California, ORIC Pharmaceuticals leverages the expertise of its scientific founders, who have extensive backgrounds in cancer research and target discovery.